← Back to All Filings

Quest Diagnostics CEO Disposes of $1.25M in Stock for Tax Purposes

Low SignificanceNovember 7, 2025 at 4:32:23 PM EST

QUEST DIAGNOSTICS INC

$DGX4CIK: 0001022079

Subscribe to track DGX

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Quest Diagnostics CEO Disposes of $1.25M in Stock for Tax Purposes

Company: QUEST DIAGNOSTICS INC (DGX) Form: 4 | Filed: 2025-11-07 Significance: Low

Insider: Davis J. E. Title: CEO and President | Relationship: Director, Officer

Transaction: • Type: Tax Withholding Sale • Shares: 7,143 • Price: $175.57 • Value: $1,253,914 • Owned After: 120,480

Key Insight: This was a non-discretionary sale (Code 'F') to cover tax obligations from vested RSUs, not an open-market sale reflecting insider sentiment.

Market Context: The transaction value represents a negligible 0.006% of the company's $19.64B market capitalization.

View Full Filing

Comprehensive Analysis

SEC Filing Analysis: QUEST DIAGNOSTICS INC (DGX)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: The CEO disposed of shares in a non-discretionary transaction to cover tax liabilities from vested restricted stock units (RSUs). This is not an indicator of insider sentiment.
  • Market Impact: Neutral. This type of transaction is routine and does not signal a change in the insider's view of the company's future prospects.

Company Information

FieldValue
CompanyQUEST DIAGNOSTICS INC
Ticker SymbolDGX
CIK0001022079
IndustryMedical Laboratories

Insider Information

FieldValue
NameDavis J. E.
CIK0001599837
Title/PositionCEO and President
RelationshipDirector, Officer

Transaction Details

FieldValue
Form Type4
Transaction Date2025-11-05
Transaction CodeF - Payment of tax liability by withholding securities
Security TypeCommon Stock
Shares Involved7,143
Price Per Share$175.57
Total Value$1,253,913.51
Shares Owned After120,480
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$1,253,913.51
% of Market Cap0.006%
Shares Transacted7,143
% of Shares Outstanding0.006%
Post-Transaction Ownership120,480 shares (0.108% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The $1.25 million transaction is immaterial relative to Quest Diagnostics' $19.64 billion market capitalization.
  • Ownership Concentration: The CEO's ownership remains at approximately 0.108% of total shares outstanding, indicating his holdings are still aligned with shareholder interests.
  • Transaction Significance: The transaction is insignificant, representing less than 0.01% of both market cap and shares outstanding. Its purpose, as a tax-related disposition, further reduces its market signaling value to zero.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction was a pre-disclosed, non-discretionary disposition to cover tax obligations. It does not reflect a voluntary decision to sell based on market conditions or company performance.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The shares were withheld by the issuer and not sold on the open market, so there is no direct impact on trading volume.
  • Sentiment Indicator: Neutral. This filing provides no bullish or bearish signals.

Additional Context

Transaction Notes

  • Special Circumstances: The filing's footnote explicitly states, "Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units." This confirms the non-discretionary nature of the event.
Topics:#SECFiling#InsiderTrading#QuestDiagnostics#DGX#Form4#StockMarket#Investing#CEO#TaxWithholding

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.